Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Merck acquires rights to atrial fibrillation candidate

April 16, 2009 Research and Development, Sales and Marketing Merck, cv

Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …
News

Simponi approved in Canada

April 16, 2009 Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …
News

Covance expands in Latin America

April 15, 2009 Research and Development Covance, Peru, South America

Covance has opened new clinical development offices in Chile and Peru, and expanded its operations in Argentina to help serve …
News

Helsinn chooses Dublin for R&D investment

April 14, 2009 Research and Development Helsinn

Helsinn Birex Pharmaceuticals is to invest 13 million euros in a new pilot-scale R&D facility in Ireland, to help it …
News

Committee approves limited use of Seroquel in depression

April 9, 2009 Research and Development, Sales and Marketing AZ, Seroquel, US

An FDA advisory committee has concluded that safety concerns mean that Seroquel XR should not be used to treat anxiety, …
News

Efient launched in the UK

April 9, 2009 Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …
News

2-in-1: Merck and Schering-Plough

April 8, 2009 Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …
Feature

Covance acquires early clinical development business in Switzerland

April 8, 2009 Research and Development Covance

Covance has expanded its presence in clinical pharmacology in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical …
News

Top CROs can look forward to ‘five years of growth’

April 8, 2009 Research and Development CRO

The current economic downturn is having a braking effect on the top 10 contract research organisations, but a new report …
News

Quintiles completes 400th trial using electronic data capture

April 7, 2009 Research and Development CRO, Quintiles

Quintiles has completed its 400th clinical trial using Electronic Data Capture (EDC). In addition to starting its 400th EDC trial, …
News

MEP animal testing vote angers welfare groups

April 7, 2009 Research and Development, Sales and Marketing Animal testing, Europe, preclinical

The European Parliament's Agriculture and Rural Development Committee has been accused of watering down proposals drawn up by the European …
News

A new approach to CRO partnerships

April 6, 2009 Research and Development Pfizer, UK, clincal, partnerships

Contract research organisations now play an indispensable role in helping pharmaceutical companies develop their drugs. But as the number and …
Feature

Lilly forges risk-sharing R&D alliance with India’s Zydus

April 6, 2009 Research and Development Asia, India, lilly

Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …
News

Consolidation wave expected in contract manufacturing

April 6, 2009 Research and Development CRO

The mergers and acquisitions that have become a feature of the contract research organisation (CRO) sector in recent years look …
News

Pfizer halts Sutent head-to-head trial

April 6, 2009 Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026